Updated August 21, 2020 – Prognosis of Diabetic Nephropathy require Persistent albuminuria (>300 mg per d otherwise >200 µg per min). These lab results must be confirmed on a minimum of two occasions 3-6 months apart. Other symptoms include a progressive decline in the glomerular filtration rate and elevated arterial blood pressure and peripheral neuropathy.
Diabetes Induced Kidney Disease
Kidney disease and lupus and heart disease are often a typical complication or side effect associated with diabetes. Statistics show that as many as 40% of the patients diagnosed with diabetes for more than 15 years acquire this complication (Diabetic Nephropathy).
Today, diabetic nephropathy is the most common type of chronic kidney disease that is treated at our regenerative stem cell hospital. Diabetic Nephropathy is also one of the most serious causes of other long-term complications that affect the morbidity and mortality of patients with diabetes. Diabetes is treatable but is directly accountable for 40-50% of all end-stage renal disease (ESRD) and polycystic kidney failure.
Diagnosis of Diabetic Nephropathy
The diagnosis of diabetes-induced Nephropathy follows screenings for microalbuminuria and routine lab urinalysis during the onset of diabetes. The Patients might emanate other signs and symptoms related with having diabetes mellitus such as strokes and autoimmune IgA nephropathy. For such cases, early diagnosis and treatment intervention using MSC+ stem cells is recommended. This prevents or at worst delays diabetes-induced kidney disease, pancreatitis, heart attacks ,ED or nephropathy from worsening.
Cell treatment of Diabetic Nephropathy offered by the Regen Center is an intensive modern medical procedure that used MSC+ renal stem cells enhanced then re-introduced into the body to transform the damaged cells into new efficiently functioning cells. The main purpose of the stem cell regeneration treatments is to repair the damaged islet-like cells to reduce glomerular hypertrophy, glomerular membrane thickness and increase in renal tubular membranes. If the patient discovers and treats the disease early with stem cell treatment for diabetic nephropathy, they will have a much better chance of fully restoring their damaged kidney functions and repairing the bodies natural function of secreting insulin.
Stem Cell Transplants for Diabetic Nephropathy
Stem cells have the ability to alter the therapy the negative effects of Diabetic Nephropathy. In numerous instances, patients have completely eliminated the need for insulin injections, medicines even dialysis. The epithelial cells of the interstitial cell and the epithelial cell brought about by chronic inflammation, virus infection, and bacterium are renewed with the aid of Mesenchymal Stem cells used in Functional medical treatments. In addition to helping regenerate the pancreas, stem cell diabetic nephropathy can also slow down or stop progressive kidney diseases while simultaneously making the immune system stronger from other harmful etiological elements.
The number of Enriched MSC+ Cell Infusions for Diabetic Nephropathy will depend on patient needs.
Type of Injections for Diabetic Nephropathy Treatment: Clinical grade enriched mesenchymal stem cells delivered in a multi-step treatment via IV Drip (homing) or Intrathecal injection and/or lumbar puncture combination.
Rehabilitation Treatment for Diabetic Nephropathy using Stem Cells: Rehabilitation therapy for Diabetic Nephropathy is available at an extra cost if needed (2 hours per day and 5 days per week) . Medical visas and accommodations for an extended stay can also be included upon request. Total time needed to treat Diabetic Nephropathy with stem cells at our treatment center in Bangkok is about 14 days.
Diabetes Nephropathy Treatment Guidelines
The Stem Cell Treatment for Diabetic Nephropathy will require a minimum of 2 weeks total in Bangkok. Due to the varying degrees/stages of organ damage, our medical team will need to better understand the patient’s condition and to pre-qualify the potential candidates before providing treatment options. Upon approval, a detailed treatment plan will be provided that will include the specifics such as the exact number of nights required in Thailand along with the total medical related costs (excluding accommodations or flights). To begin the qualification process for our multi-stage treatment protocol please prepare your recent medical records such as (Blood Panels, Genetic Tests for Diabetic Nephropathy and Radiology scan from MRI, CT or Ultrasound Scans) and contact us today.
Published Clinical Citations
 ^ Yang, Guang, and Qing-li Cheng. 2013. [Stem cells and diabetic nephropathy]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, no. 3 ( 18). https://www.ncbi.nlm.nih.gov/pubmed/23774938
 ^ Lee, Seung Eun, Jung Eun Jang, Hyun Sik Kim, Min Kyo Jung, Myoung Seok Ko, Mi-Ok Kim, Hye Sun Park, et al. 2019. Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells. Experimental & molecular medicine, no. 7 (July 9). doi:10.1038/s12276-019-0268-5. https://www.ncbi.nlm.nih.gov/pubmed/31285429
 ^ Hamza, Amal H, Widad M Al-Bishri, Laila A Damiati, and Hanaa H Ahmed. 2016. Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy. Renal failure, no. 1 (October 23). doi:10.1080/0886022X.2016.1244080. https://www.ncbi.nlm.nih.gov/pubmed/27774826
 ^ Bochon, Benjamin, Magdalena Kozubska, Grzegorz Surygała, Agnieszka Witkowska, Roman Kuźniewicz, Władysław Grzeszczak, and Grzegorz Wystrychowski. 2019. Mesenchymal Stem Cells-Potential Applications in Kidney Diseases. International journal of molecular sciences, no. 10 (May 18). doi:E2462. https://www.ncbi.nlm.nih.gov/pubmed/31109047